Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
Related Posts
Publication: Aeroplane wing, a new recessive autosomal phenotypic marker in malaria vector, Anopheles stephensi Liston
Aeroplane wing, a new recessive autosomal phenotypic marker in malaria vector, Anopheles... read more
WHONET 2 day workshop – Dr. Mansi Malik
Antimicrobial resistance (AMR) has been identified as a serious global and national... read more
Stem Cell technology offers new hope for treating rare genetic disorders
Stem cell technology has witnessed advancement that open new hopes for the... read more
MoU Signing with ICAR – National Bureau of Agricultural Insect Resources (NBAIR)
Insects play a vital role in agriculture and for our well-being. They... read more
Sewage surveillance shows consistent COVID positivity in 13 out of 28 STPs in Bengaluru
Our efforts on the environmental surveillance of COVID19 pandemic in Bengaluru city... read more
Talk by Dr. Farah Ishtiaq on Genomic Surveillance to track diseases in wastewater
Dr. Farah Ishtiaq, Principal Scientist at TIGS, gave a talk on the... read more
Delegation visit from Swissnex in India
We were pleased to host a delegation from Swissnex in India to... read more
India must scale up wastewater analysis for health surveillance
In this latest opinion piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS... read more
Indian Academy of Sciences launch symposium for the release of a special issue on the ‘Rare Genetic Diseases Landscape in India’
Recently the Journal of Biosciences, Indian Academy of Sciences held a launch... read more